Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05252390
Title NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nuvation Bio Inc.
Indications

prostate cancer

Advanced Solid Tumor

ovarian cancer

peritoneum cancer

fallopian tube cancer

pancreatic cancer

triple-receptor negative breast cancer

Therapies

NUV-868

NUV-868 + Olaparib

Enzalutamide + NUV-868

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.